SEATTLE, WA, February 11, 2010 – Amnis Corporation, a manufacturer of advanced cell imaging systems, today announced record 2009 sales results. The successful launch of the ImageStreamX imaging flow cytometer resulted in annual sales growth in excess of 75% and the company's first cash flow positive quarter. Strong early sales for the new instrument consumed the company's manufacturing capacity for 2009 and well into 2010.
Download the Press Release (Adobe PDF)
SEATTLE, WA, November 18, 2009 – Amnis Corporation was included in a piece on National Public Radio's All Things Considered entitled, "Counting Stimulus Jobs is Tough Work." NPR reporter Martin Kaste visited Amnis to learn how stimulus funding is helping to get the company's "super-microscopes" into the hands of life sciences researchers.
Listen to the Story (Link to the NPR website)
SEATTLE, WA, October 20, 2009 – Amnis Corporation, a manufacturer of advanced cell imaging systems, has named Chris Doman as its Vice President of Sales. Doman joined Amnis in June of 2008 as Director of International Sales with over 25 years of extensive international experience in the biotechnology and medical device markets.
Download the Press Release (Adobe PDF)
SEATTLE, WA, October 6, 2009 – Amnis Corporation, a manufacturer of advanced cell imaging systems, today announced the first commercial shipments of the new ImageStreamX imaging flow cytometers. The new instrument - the second generation of Amnis' patented ImageStream® technology - combines the speed, sensitivity, and phenotyping abilities of flow cytometry with the detailed imagery, rich feature set, and functional insights of microscopy.
Download the Press Release (Adobe PDF)
SEATTLE, WA, May 8, 2009 – Amnis Corporation, a manufacturer of advanced cell imaging systems, today announced the launch of the new ImageStreamX imaging flow cytometer. The new instrument – the second generation of the patented ImageStream® technology – combines the speed, sensitivity, and phenotyping abilities of flow cytometry with the detailed imagery and functional insights of microscopy. The new ImageStreamX greatly expands the capabilities of the platform with faster sample throughput, more excitation lasers and detection channels, higher image quality, and greater productivity.
Download the Press Release (Adobe PDF)
SEATTLE, WA, April 21, 2009 – Amnis Corporation, a manufacturer of advanced cell imaging systems, announced today that it has received U.S. patent 7,522,758. The patent, entitled Blood and Cell Analysis Using an Imaging Flow Cytometer, broadly covers diagnostic uses of multispectral cell imaging in flow or on slides and expands the company’s intellectual property estate to 32 issued U.S. patents plus multiple foreign counterparts.
Download the Press Release (Adobe PDF)
SEATTLE, WA, 5/22/08 - Amnis Corporation announced today the commercial release of its Extended Depth of Field (EDFTM) option for the ImageStream system. This technology breaks through classical depth of field limitations of high resolution optical systems, thereby improving the performance of the ImageStream system and enabling new applications including high speed analysis of fluorescence in-situ hybridization (FISH). The EDF option can be installed at time of manufacture or in the field to allow the existing customer base to take advantage of this new capability.
Download the Press Release (Adobe PDF)
SEATTLE, WA, 5/07/08 - Amnis Corporation and Gene Company, Ltd. announced today the completion of an agreement under which Gene Company will sell and service the Amnis ImageStream® system in China. Effective immediately, the scientific research communities in Hong Kong, Shanghai, Beijing and Guangzhou now have access to this important cell analysis technology.
Download the Press Release (Adobe PDF)
SEATTLE, WA, 8/23/07 - Amnis Corporation announced today the release of two major upgrades to its ImageStream system including the Commercial release of a multilaser capability and the Beta release of a new technology for dramatically extending the depth of field well beyond conventional optical limitations.Amnis is proud to offer the ImageStream system, a single platform that combines the analytical power of quantitative cell imaging with the statistical power of flow cytometry.
Download the Press Release (Adobe PDF)
SEATTLE, WA, 7/25/06 - Amnis Corporation, a manufacturer of advanced instrumentation for the life science research and diagnostics markets, announced today the publication of a major new study in the field of AIDS research. The pioneering work, involving the development of a robust murine model for long-term KSHV infection, was carried out by Dr. Dean Kedes and colleagues at the University of Virginia Health System. KSHV, a γ herpesvirus, is the etiologic agent of Kaposi’s sarcoma, the most common AIDS-associated malignancy worldwide.
Download the Press Release (Adobe PDF)
2505 Third Avenue, Suite 210 | Seattle, WA 98121 | p: 800 730 7147 | f: 206 576 6895
© 2010 Amnis Corporation. All Rights Reserved.